1 result(s) for LEE011
|PI Name||Protocol #||Title|
|Zahi Mitri||STUDY00017016||[Quorum] COMPLEEMENT-1: An open-label, multicenter, Phase IIIb study to assess the safety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease|
You may also qualify for Phase 1 Program trials.
For more information: